H.C. Wainwright (Rodman & Renshaw) Starts Second Sight Medical (EYES) at Buy
Get Alerts EYES Hot Sheet
Price: $4.14 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
H.C. Wainwright (Rodman & Renshaw) initiated coverage on Second Sight Medical (NASDAQ: EYES) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Second Sight Medical click here. For more ratings news on Second Sight Medical click here.
Shares of Second Sight Medical closed at $14.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Affirm stock drops on report Walmart-backed fintech One is launching BNPL; Mizuho says 'concerns overblown'
- William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
- Texas Instruments (TXN) jumps as on earnings, revenue beat in fiscal Q1
Create E-mail Alert Related Categories
Hot New Coverage, Momentum Movers, New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!